全球心律調節管理市場

Abstract

Market demand, innovative products, government regulations and reimbursement policies are the four factors that have been changing the global healthcare industry continuously. These factors have also influenced the market for specialized medical devices - Cardiac Rhythm Management (CRM), which mainly comprises Implantable Cardiac Rhythm Devices (ICD) and Pacemakers.

ICDs constitute more than 60% of the global CRM market and served as the major growth driver for CRM market. However, in 2006, the market registered a negligible growth following product recalls by leading companies like Medtronic and Guidant/Boston Scientific. Nevertheless the ICDs segment is expected to grow at a satisfactory rate 2008 onwards and specifically in Europe and other emerging countries.

The recall of ICDs by world' s top medical device manufacturers -- Medtronic and Guidant/Boston Scientific in 2005 became the major reason behind the market slow down during 2006.

On the other hand, the market for pacemakers is heading towards saturation especially in the USA and Europe because of the high penetration rates by population in these regions. Still, in Japan and in other Asian countries like China and India, it holds tremendous potential.

The current report analyzes the CRM market with specific focus on ICDs. In the present study, the growth of ICDs and pacemakers in the last four years has been assessed and the future potential of these markets has been studied. As only three companies -- Medtronic, St. Jude and Boston Scientific is defining this market space, these companies have been profiled and their strategies mapped. Further, the report also presents an assessment of the future of the CRM market.

Table of Contents

• 1. Cardiovascular Diseases: Incidence and Treatment
  • 1.1 Cardiovascular Diseases in United States
  • 1.2 Sudden Cardiac Death (SCD) and Cardiac Rhythm Management
  • 1.3 The MADIT Trial and Medical Reimbursements
• 2. Cardiac Rhythm Management Market
• 3. Implantable Cardiac Rhythm Devices (ICD) Market
• 4. Pacemaker Market
• 5. Growth of ICD Market by Geography
• 6. Competitive Landscape
  • 6.1 Cardiac Rhythm Management (CRM) Market
  • 6.2 Implantable Cardioverter Defibrillator (ICD) Market
  • 6.3 Pacemaker market
• 7. Leading Players
  • 7.1 Medtronic
    • 7.1.1 Company Profile
    • 7.1.2 Medtronic - Distribution Methods
    • 7.1.3 Business Strategies
  • 7.2 Boston Scientific
    • 7.2.1 Company Profile
    • 7.2.2 Boston Scientific -- Distribution Methods
    • 7.2.3 Business Strategies
  • 7.3 St. Jude Medical
    • 7.3.1 Company Profile
    • 7.3.2 Business Strategies
• 8. Outlook

List of Figures, Charts, and Tables

Figures and Tables

• Figure 1.1: Cardiovascular disease in the US by demographics
• Figure 2.1: Global Cardiac Rhythm Management Market: Market Size and Growth (2003-2006)
• Figure 2.2: US Cardiac Rhythm Management (CRM) Market: Market Size and Growth (2003-2010)
• Figure 3.1: Global Implantable Cardioverter Defibrillator systems (ICD) Market: Market Size and Growth (2003-2006)
• Figure 4.1: Global Pacemaker Market: Market Size and Growth (2004-2006)
• Figure 4.2: Pacemakers - Penetration rates: 2006
• Figure 5.1: Global ICD market by geography: 2006
• Figure 6.1: Global Market Share of Leading CRM Manufacturers: 2004-2009
• Figure 6.2: Global Market Share of Leading ICD Manufacturers: 2004-2009
• Figure 6.3: Global Market Share of Leading Pacemaker Manufacturers: 2004-2009
• Figure 7.1: Medtronic -- Sales by operating segment - 2007
• Figure 7.2: Boston Scientific: Sales by Segment - 2006
• Figure 7.3: St. Jude: Sales by Segment - 2006
• Figure 8.1: Global Cardiac Rhythm Management Market Forecast: Market Size and Growth (2007-2010)
• Figure 8.2: Global Pacemaker Market Forecast: Market Size and Growth (2007-2009)
• Figure 8.3 Global Implantable Cardioverter Defibrillator systems (ICD) Market Forecast: Market Size and Growth (2007-2009)